Regulus Therapeutics
RGLS
#7200
Rank
โ‚ฌ0.51 B
Marketcap
7,44ย โ‚ฌ
Share price
0.00%
Change (1 day)
464.66%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of March 2025 : โ‚ฌ68.19 Million

According to Regulus Therapeutics's latest financial reports the company's total assets are โ‚ฌ68.19 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ80.89 M190.82%
2023-12-31โ‚ฌ27.81 M-36.13%
2022-12-31โ‚ฌ43.55 M-27.95%
2021-12-31โ‚ฌ60.44 M97.71%
2020-12-31โ‚ฌ30.57 M-18.61%
2019-12-31โ‚ฌ37.56 M53.88%
2018-12-31โ‚ฌ24.41 M-62.36%
2017-12-31โ‚ฌ64.84 M-32.24%
2016-12-31โ‚ฌ95.69 M-25.83%
2015-12-31โ‚ฌ0.12 B-8.49%
2014-12-31โ‚ฌ0.14 B58.22%
2013-12-31โ‚ฌ89.11 M13.87%
2012-12-31โ‚ฌ78.25 M137.01%
2011-12-31โ‚ฌ33.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
โ‚ฌ134.24 B 196,756.71%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ29.24 B 42,781.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ80.90 B 118,537.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ105.57 B 154,703.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ86.67 B 127,000.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚ฌ54.65 M-19.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ7.28 B 10,584.35%๐Ÿ‡บ๐Ÿ‡ธ USA